Search
for
Sort by
Research 30 of 493
- Isolated depressive disorders and suicidality with finasteride use for androgenetic alopecia: a call for enhanced vigilance
- Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment
- Finasteride linked with suicidal ideation/self-harm
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- The Relationship Between Depression Levels and Suicide Risk in Pediatric Patients with Alopecia Areata and the Oxidant-Antioxidant Balance
- Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study
- Pharmacologic Modulation of Sebaceous Gland Activity: Mechanisms and Clinical Applications
- Risk of New-Onset Postoperative Depression After Holmium Laser Enucleation Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: A Nationwide Retrospective Cohort Study
- Mood disorders and quality of life in polycystic ovary syndrome
- Feasibility of implementing current best clinical practice for people who are using anabolic androgenic steroids within a Swiss primary care practice: a quality assurance study
- Endocrine intervention for transsexuals
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- Psychological assessment in 355 Chinese college students with androgenetic alopecia
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Risk Factors and Epidemiology of Acne Severity and Acne Scar Development: A Comprehensive Clinical Study
- Atopic dermatitis and risk of autoimmune diseases: a systematic review and meta-analysis
- Do Alpha-Blockers and 5-Alpha Reductase Inhibitors Increase Dementia Risk? A Network Meta-analysis
- Considerations in genetic counseling of transgender patients: Cultural competencies and altered disease risk profiles
- Guidelines for the Use of Acitretin in Psoriasis
- Isotretinoin-based treatment in patients with acne: main physiological and psychological effects
- Cicatricial (Scarring) Alopecias
- Topical Minoxidil
- Signal detection between 5-alpha reductase inhibitors and the risk of suicidality and depression: an international pharmacovigilance analysis
- Risk of Depression after 5 Alpha Reductase Inhibitor Medication: Meta-Analysis
- Risk factors for androgenetic alopecia: a systematic review and meta-analysis
- Hair stress hormones in individuals with a recent suicide attempt experiencing a depressive episode
- Beyond Clinical Efficacy: A Literature Review on the Safety Challenges of Isotretinoin Therapy
- Women's Skin throughout Lifetime
- Transsexualism